Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	41	non-cytoplasmic
42	62	transmembrane
63	93	cytoplasmic
94	118	transmembrane
119	144	non-cytoplasmic
145	164	transmembrane
165	175	cytoplasmic
176	196	transmembrane
197	215	non-cytoplasmic
216	241	transmembrane
242	252	cytoplasmic
253	276	transmembrane
277	311	non-cytoplasmic
312	312	cytoplasmic
313	337	transmembrane
338	356	cytoplasmic
357	382	transmembrane
383	383	cytoplasmic
384	387	non-cytoplasmic
388	388	cytoplasmic
389	406	transmembrane
407	424	cytoplasmic
425	425	non-cytoplasmic
426	450	transmembrane
451	452	non-cytoplasmic

Input:
>5207779
MSAKDLGHFSSRIGFIMAAAGSAVGVGNIWGFPTQAATHGGGAFLLVYLVLIFLLGYPML
VAELMIGRHGQTNPADAMAKLGSSKLSRNLGKTIGFASIITATLICTFYSILSGWFVSFT
LAPIARLVGMQDIALWLTSFSLERNLLFTLIFILMVVLVIRQGVQQGIEAWSKRLMPLLL
AILILGVAYILTQPGASQGLNALLVPDFGRIWEPQVLIGALGQTFFSLTVGTGAMMVYGA
YLNRQENLAKLTAYVTLTDTSVAFLAALMIIPAMYVAQHNGVQIFAADGSLLNADTLVFT
VLPALFDSLGGLAGQLIAIVFFILMTIAGLTSAISIVEVPTSYMVEKTEIQRHSATYLVG
GGIALLATIMVFNFDALFALVITLTTERAQPFIALGIALYTGWVWHRNSLLKAIAAQEGA
KLDGLFWRIWPVYVKYVCPVLILAIILQLLTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server